Notice on Convening the 4th Extraordinary General Meeting in 2025

About this update from Shanghai Rightongene Biotechnology Co. Ltd. Class A

Notice on Convening the 4th Extraordinary General Meeting in 2025The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Rightongene Biotechnology Co. Ltd. Class A